Enanta Pharmaceuticals Inc. (ENTA) stock forecast and price target
Price $10.99 · data as of November 13, 2026
12-month price target
Average target$21.83
Upside / downside+98.7%
Analysts6
ConsensusNone
Low $19.00Average $21.83High $32.00
Gold marker: average target · white marker: today’s price ($10.99)
Analyst ratings
Strong buy 1Buy 5Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Next fiscal year ends September 30, 2027 | $-2.37 | −3.6% | $64M |
| Quarter after ends December 31, 2026 | $-0.41 | +3.6% | $16M |
Consensus of the analysts covering Enanta Pharmaceuticals, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.
Frequently asked questions
What is the Enanta Pharmaceuticals stock price target?
The average 12-month target from 6 analysts is $21.83, 98.7% above the current price of $10.99 Targets range from $19.00 to $32.00.
Is Enanta Pharmaceuticals a buy according to analysts?
The consensus rating is “None” (1 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.